On March 30, the “2022 Advanced Technology Convention for Novel Biologics” will be held as scheduled, in which first-class experts inprocess and industrialization technology will share their experience and the prospects in the application of advanced production technology, and systematically discusse the technical key points in the development and commercialization of innovative drugs development. Dr. Peng Huang, head of ADC R&D of TOT BIOPHARM, will share Challenges and Strategies of ADC Drug Development at 13:45 on the afternoon of the 30th, and TOT BIOPHARM will set up a virtual booth at the exhibition.